Company intelligence / Profile preview

JMDNA Biomedical Technology

Shanghai, Shanghai Shi, China

Ownership: Private
Employees: ~100
Development stage: Other

Overview

JMDNA provides large-scale gene sequencing and molecular diagnostics; by 2023 it became the world's first enterprise user of the ultra-high-throughput DNBSEQ-T20×2 sequencer, enabling population-scale genomics and precision medicine applications.[7][9][11]

Therapeutic areas: Women's HealthOtherRare Diseases
Industry: Molecular Diagnostics

Partnerships

MGI

Beyond the preview

Go deeper on JMDNA Biomedical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JMDNA Biomedical Technology.

Explore the full profile